These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7401365)

  • 1. [A study of the cell-mediated immunity in chronic inflammatory bowel disease: role of the enterobacterial common antigen (author's transl)].
    Tanaka T
    Nihon Shokakibyo Gakkai Zasshi; 1980 May; 77(5):722-31. PubMed ID: 7401365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological study on ulcerative colitis: lymphocyte-mediated cytotoxicity by colonic mucosal and enterobacterial antigens (author's transl)].
    Yamaguchi K; Kobayashi K; Murai M; Tanaka Y; Katayama T; Kuwajima S; Kitano A; Kinoshita Y; Yamamoto S
    Nihon Shokakibyo Gakkai Zasshi; 1978 Dec; 75(12):1924-33. PubMed ID: 739625
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease.
    Ibbotson JP; Lowes JR; Chahal H; Gaston JS; Life P; Kumararatne DS; Sharif H; Alexander-Williams J; Allan RN
    Clin Exp Immunol; 1992 Feb; 87(2):224-30. PubMed ID: 1735186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease.
    Shorter RG; Huizenga KA; Spencer RJ
    Am J Dig Dis; 1972 Nov; 17(11):1024-32. PubMed ID: 5082428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunoadjuvant activity of phospholipids extracted from animal tissues (intestine, liver and brain) to ovalubumin and enterobacterial common antigen (ECA), and their possible role in the chronic inflammatory bowel disease (author's transl)].
    Tanaka Y; Kobayashi K; Murai M; Katayama T; Yamaguchi K; Kuwajima S; Kitano A; Yamamoto S; Yano I; Masui M
    Nihon Shokakibyo Gakkai Zasshi; 1980 Mar; 77(3):361-7. PubMed ID: 7382138
    [No Abstract]   [Full Text] [Related]  

  • 6. Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease.
    Bull DM; Ignaczak TF
    Gastroenterology; 1973 Jan; 64(1):43-50. PubMed ID: 4567283
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent developments in nonspecific inflammatory bowel disease (second of two parts).
    Kirsner JB; Shorter RG
    N Engl J Med; 1982 Apr; 306(14):837-48. PubMed ID: 7038490
    [No Abstract]   [Full Text] [Related]  

  • 8. [The immunology of inflammatory bowel disease (author's transl)].
    Bartnik W; Shorter RG
    Przegl Lek; 1981; 38(6):481-9. PubMed ID: 7268048
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunology of chronic ulcerative colitis and Crohn's disease.
    Shorter RG; Tomasi TB; Huizenga KA; Spencer RJ; Stobo JD
    Ann N Y Acad Sci; 1976; 278():586-91. PubMed ID: 786126
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of peripheral leucocyte migration in agarose medium in inflammatory bowel disease.
    Bartnik W; Swarbrick ET; Williams C
    Gut; 1974 Apr; 15(4):294-300. PubMed ID: 4834555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular and humoral immunity in chronic intestinal inflammatory disease. Our results with an in vitro test].
    Velo Bellver JL; Rabago Torre L; Medina MC; López de la Riva M; Clemente G; Castellanos D; Poves E; Robles J; Alcalá R
    Rev Esp Enferm Apar Dig; 1985 May; 67(5):409-15. PubMed ID: 4023369
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro lymphocyte response to non-specific mitogens in inflammatory bowel disease.
    Asquith P; Kraft SC; Rothberg RM
    Gut; 1972 Apr; 13(4):320. PubMed ID: 5033849
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte transformation to specific antigens associated with Crohn's disease.
    Graham J; Whorwell PJ; Machin D; Wright R
    Hepatogastroenterology; 1981 Oct; 28(5):258-60. PubMed ID: 6284623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the activity to induce and activate delayed hypersensitivity of enterobacterial common antigen and bacterial lipopolysaccharide (author's transl)].
    Kuwajima S; Kobayashi K; Murai M; Tanaka Y; Yamaguchi K; Kitano A; Yamamoto S
    Nihon Shokakibyo Gakkai Zasshi; 1979 Aug; 76(8):1642-51. PubMed ID: 537191
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immune reactions against common antigen, small intestine, and colon antigen in patients with Crohn's disease, ulcerative colitis, and cirrhosis of the liver.
    Eckhardt R; Heinisch M; Meyer zum Büschenfelde KH
    Scand J Gastroenterol; 1976; 11(1):49-54. PubMed ID: 1251132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal humoral and cellular immunity in ulcerative colitis and Crohn's disease].
    Asakura H; Tanaka T; Hibi T; Miura S; Mizuno Y; Oda Y; Tsuchiya M
    Nihon Rinsho; 1977 May; 35(5):1828-35. PubMed ID: 301952
    [No Abstract]   [Full Text] [Related]  

  • 17. Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease.
    Bull DM; Ignaczak TF; Greenberger NJ
    J Lab Clin Med; 1971 Nov; 78(5):826. PubMed ID: 5128870
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cell immunity reactions in ulcerative colitis (author's transl)].
    Fixa B; Komárková O
    Cesk Gastroenterol Vyz; 1974 Mar; 28(2):95-9. PubMed ID: 4132411
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunopathology of ulcerative colitis and granulomatous colitis (author's transl)].
    Bläker F
    Leber Magen Darm; 1975 Aug; 5(4):167-71. PubMed ID: 1223564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological aspects of ulcerative colitis (author's transl)].
    Kato S; Sawai K; Suto Y; Kohli Y; Yamaguchi N
    Nihon Shokakibyo Gakkai Zasshi; 1977 Jul; 74(7):883-91. PubMed ID: 904090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.